tiprankstipranks
Noxopharm Ltd. (AU:NOX)
ASX:NOX
Australian Market
Holding AU:NOX?
Track your performance easily

Noxopharm Ltd. (NOX) Income Statement

2 Followers

Noxopharm Ltd. Income Statement

Last quarter (Q4 2022), Noxopharm Ltd.'s total revenue was AU$―, a decrease of ― from the same quarter last year. In Q4, Noxopharm Ltd.'s net income was AU$―. See Noxopharm Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20Jun 19Jun 18
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
-AU$ 15.21MAU$ 20.21MAU$ 16.37MAU$ 15.68MAU$ 10.51M
Operating Income
-AU$ -15.21MAU$ -20.21MAU$ -16.37MAU$ -15.68MAU$ -10.51M
Net Non Operating Interest Income Expense
-AU$ -30.39KAU$ -2.05MAU$ -3.46MAU$ -464.21KAU$ -175.49K
Other Income Expense
-AU$ -3.43MAU$ 12.91MAU$ 18.82MAU$ 3.57MAU$ -7.64M
Pretax Income
-AU$ -18.67MAU$ -9.35MAU$ -999.57KAU$ -12.57MAU$ -18.32M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-AU$ -18.67MAU$ -9.35MAU$ -272.09KAU$ -11.22MAU$ -18.28M
Basic EPS
-AU$ -0.06AU$ -0.04AU$ >-0.01AU$ -0.08-
Diluted EPS
-AU$ -0.06AU$ -0.04AU$ >-0.01AU$ -0.08-
Basic Average Shares
-AU$ 291.22MAU$ 263.85MAU$ 138.36MAU$ 138.15M-
Diluted Average Shares
-AU$ 291.22MAU$ 263.85MAU$ 138.36MAU$ 138.15M-
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
------
Net Income From Continuing And Discontinued Operation
-AU$ -18.67MAU$ -9.35MAU$ -272.09KAU$ -11.22MAU$ -18.28M
Normalized Income
-AU$ -18.67MAU$ -9.35MAU$ -272.09KAU$ -11.22MAU$ -18.28M
Interest Expense
-AU$ 77.33KAU$ 2.19MAU$ 3.47MAU$ 650.90KAU$ 238.30K
EBIT
-AU$ -18.59MAU$ -7.16MAU$ 2.47MAU$ -11.92MAU$ -18.08M
EBITDA
-AU$ -18.33MAU$ -6.90MAU$ 2.71MAU$ -11.86MAU$ -18.02M
Currency in AUD

Noxopharm Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis